RPCA
Running Point Capital Advisors’s Eli Lilly LLY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.79M | Sell |
2,291
-43
| -2% | -$33.5K | 0.49% | 39 |
|
|
2025
Q1 | $1.93M | Buy |
2,334
+476
| +26% | +$393K | 0.61% | 37 |
|
|
2024
Q4 | $1.43M | Buy |
1,858
+27
| +1% | +$20.8K | 0.49% | 38 |
|
|
2024
Q3 | $1.62M | Sell |
1,831
-21
| -1% | -$18.6K | 0.63% | 36 |
|
|
2024
Q2 | $1.68M | Sell |
1,852
-28
| -1% | -$25.3K | 0.69% | 36 |
|
|
2024
Q1 | $1.46M | Buy |
1,880
+854
| +83% | +$664K | 0.65% | 39 |
|
|
2023
Q4 | $598K | Buy |
1,026
+21
| +2% | +$12.2K | 0.29% | 54 |
|
|
2023
Q3 | $540K | Buy |
1,005
+8
| +0.8% | +$4.3K | 0.31% | 51 |
|
|
2023
Q2 | $468K | Buy |
997
+11
| +1% | +$5.16K | 0.26% | 61 |
|
|
2023
Q1 | $339K | Hold |
986
| – | – | 0.21% | 67 |
|
|
2022
Q4 | $361K | Buy |
986
+22
| +2% | +$8.05K | 0.22% | 65 |
|
|
2022
Q3 | $312K | Buy |
964
+85
| +10% | +$27.5K | 0.21% | 66 |
|
|
2022
Q2 | $285K | Buy |
879
+2
| +0.2% | +$648 | 0.18% | 69 |
|
|
2022
Q1 | $251K | Buy |
877
+16
| +2% | +$4.58K | 0.15% | 82 |
|
|
2021
Q4 | $238K | Buy |
+861
| New | +$238K | 0.14% | 70 |
|